Dr. Anemaria Lutas, MD

Dr. Lutas practices at MUSC Health at North Area Medical Pavilion in North Charleston, South Carolina.

Dr. Lutas' NPI, 1437115870, was assigned on April 25, 2006. Dr. Lutas holds South Carolina license 38719.

Dr. Lutas' primary practice is MUSC Health at North Area Medical Pavilion, at 8992 University Blvd, North Charleston, SC 29406 in Charleston County. The practice phone is (843) 792-6200.

Dr. Lutas' primary practice is MUSC Health at North Area Medical Pavilion in North Charleston, South Carolina. Dr. Lutas is also affiliated with Candler Hospital. The medical group on file is MUSC Health Primary Care (Citadel Mall). Dmand AI also links Dr. Lutas to 3 more hospitals, 3 home health agencies, 2 group practices and clinics, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lutas practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lutas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Lutas' licenses on file in 3 states: South Carolina, Illinois and Indiana.

CMS data shows 213 Medicare services from Dr. Lutas across 6 procedure codes in 2024, for 145 Medicare patients. Medicare paid $9,739 for them. Every service was in an office.

CMS counts 145 Medicare patients who saw Dr. Lutas in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lutas' median patient age at 73, with 69% women.

In 2024, Dr. Lutas wrote 3,194 Medicare Part D claims for 406 patients. 86% of them were for generic drugs. CMS names the drug for 2,476 of them, across 76 drugs with 11 or more claims each, at $170,758 in total drug cost. In 2023, CMS named 6,454 claims across 147 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lutas for performance year 2024, reported as part of a group. Dr. Lutas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Dr. Lutas from 7 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $38.